Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs-Reference-Cited by-同舟云学术

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs

Published:2020-06-11 Issue:8 Volume:79 Page:991-993
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Isaacs John D^ORCID,Burmester Gerd R^ORCID

Funder

Versus Arthritis

National Institute for Health Research

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference15 articles.

1. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?

2. Risk of serious infection among initiators of TNF inhibitors plus methotrexate versus triple therapy for rheumatoid arthritis: a cohort study;Kang;Arthritis Care Res,2019

3. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis

4. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

5. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review;International Journal of Molecular Sciences;2024-09-07

2. Prevalence of Apical Periodontitis in Patients with Autoimmune Liver Diseases on Immune Suppressants and Immune Modulators: A Cross-sectional Study;Journal of Endodontics;2024-06

3. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29

4. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study;RMD Open;2023-11

5. Post-COVID syndrome: rheumatological aspects;Vrach;2023-07-07